|
Strategy
Facts
 Pipeline
Key figures
Outlook
Share
Announcements
Financial reports
Presentations
Annual General Meeting
Corporate Governance
Dates & Events
Annual Document
IR Service
|  Key
figures
| Earnings in ’000 Euro |
20091) |
2008
|
2007
|
| Sales revenue |
10,000 |
0 |
0 |
Other income
|
3,013 |
3,208 |
2,583
|
Other expenses
|
(25,878)
|
(24,601)
|
(2,.510)
|
of which research and development
|
(21,823)
|
(20,157)
|
(22,999)
|
Operating result
|
(12,864)
|
(21,394)
|
(23,927)
|
Earnings before tax
|
(12,714)
|
(20,433)
|
(22,234)
|
Net loss for the period
|
(12,729)
|
(20,448)
|
(22,258)
|
Earnings per share in euros
|
(0.95)
|
(1.71)
|
(1.86)
|
Balance sheet as of end of period in ’000
Euro
|
|
|
|
Total assets
|
12,013
|
15,327
|
37,627
|
Cash and cash equivalents
|
3,411
|
12,137
|
34,170
|
Equity
|
3,045
|
5,790
|
25,951
|
Equity ratio 2) in
%
|
25.3
|
37.8
|
69.0
|
Cash flow in ’000
Euro
|
|
|
|
from operating activities
|
(18,638)
|
(22,830)
|
(22,659)
|
| from investing activities |
(71)
|
14,932
|
(15,599)
|
from financing activities
|
9,794
|
(89)
|
(960)
|
Employees
|
|
|
|
| Employees as of end of period 3) |
71 |
66
|
57
|
1) The reporting period begins
on 1 December and ends on 30 November.
2) Equity / total assets
3) Including members of the Executive Management Board
| |
